American International Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-41,767
Closed -$307K 932
2024
Q1
$307K Sell
41,767
-359
-0.9% -$2.64K ﹤0.01% 1904
2023
Q4
$158K Sell
42,126
-171
-0.4% -$640 ﹤0.01% 2298
2023
Q3
$89.7K Buy
42,297
+1,505
+4% +$3.19K ﹤0.01% 2564
2023
Q2
$194K Buy
40,792
+673
+2% +$3.2K ﹤0.01% 2185
2023
Q1
$229K Buy
40,119
+798
+2% +$4.55K ﹤0.01% 2038
2022
Q4
$397K Sell
39,321
-142
-0.4% -$1.43K ﹤0.01% 1728
2022
Q3
$884K Buy
39,463
+556
+1% +$12.5K 0.01% 1251
2022
Q2
$964K Sell
38,907
-1,389
-3% -$34.4K 0.01% 1222
2022
Q1
$1.56M Sell
40,296
-2,835
-7% -$110K 0.01% 1112
2021
Q4
$2.52M Sell
43,131
-1,291
-3% -$75.5K 0.01% 985
2021
Q3
$2.63M Sell
44,422
-506
-1% -$30K 0.01% 953
2021
Q2
$3.9K Sell
44,928
-1,536
-3% -$133 0.01% 899
2021
Q1
$3.83K Buy
46,464
+2,466
+6% +$203 0.01% 908
2020
Q4
$4K Buy
43,998
+1,163
+3% +$106 0.01% 858
2020
Q3
$1.71M Buy
42,835
+4,529
+12% +$181K 0.01% 1011
2020
Q2
$1.31M Buy
38,306
+2,393
+7% +$82.1K 0.01% 1099
2020
Q1
$798K Sell
35,913
-2,075
-5% -$46.1K ﹤0.01% 1207
2019
Q4
$743K Buy
37,988
+4,954
+15% +$96.9K ﹤0.01% 1481
2019
Q3
$513K Sell
33,034
-229
-0.7% -$3.56K ﹤0.01% 1641
2019
Q2
$675K Sell
33,263
-5,416
-14% -$110K ﹤0.01% 1531
2019
Q1
$680K Sell
38,679
-1,254
-3% -$22K ﹤0.01% 1539
2018
Q4
$512K Buy
39,933
+6,616
+20% +$84.8K ﹤0.01% 1661
2018
Q3
$543K Buy
33,317
+943
+3% +$15.4K ﹤0.01% 1841
2018
Q2
$367K Buy
32,374
+1,510
+5% +$17.1K ﹤0.01% 2021
2018
Q1
$301K Buy
30,864
+5,181
+20% +$50.5K ﹤0.01% 2018
2017
Q4
$157K Buy
25,683
+122
+0.5% +$746 ﹤0.01% 2465
2017
Q3
$101K Buy
25,561
+1,911
+8% +$7.55K ﹤0.01% 2651
2017
Q2
$77K Buy
+23,650
New +$77K ﹤0.01% 2871
2014
Q2
Sell
-99
Closed -$964 4939
2014
Q1
$964 Hold
99
﹤0.01% 4731
2013
Q4
$622 Buy
+99
New +$622 ﹤0.01% 4685